
GLP-1 Drugs May Cut Risk of 4 Cancers by Up to 50%, Scientists Find
New research suggests GLP-1 medicines may be linked to a lower risk of several obesity-related cancers, but scientists caution the findings do not prove the drugs directly prevent cancer. Use of GLP-1 drugs including Ozempic and Wegovy has surged in…















